Authors



Samuel L. Aitken, PharmD, MPH

Latest:

Current and Potential Treatment Options for Stenotrophomonas maltophilia Infections

We review current and emerging treatment options for infections caused by the difficult-to-treat, intrinsically multidrug-resistant organism Stenotrophomonas maltophilia.


Susan A. Innis, MD

Latest:

An Unusual Case of Testicular Swelling in a Patient With HIV

Being immunocompromised increases risk of rare Mycobacterium tuberculosis epididymo-orchitis.



Alexander Kantorovich, PharmD, BCPS

Latest:

Community Acquired Pneumonia and the Role of Adjunctive Corticosteroids

Antibiotics are the mainstay treatment for CAP; however, the additive role of corticosteroids is continually being debated.


BENJAMIN BLUEN, MD

Latest:

Cryptosporidium: A Potentially Fatal Cause of Diarrhea in a Heart Transplant Recipient

Expanding the differential for diarrhea beyond Clostridium difficile.


Pattie Jakel, MN, RN, AOCN

Latest:

Evidence-Based Intervention Reduces C. diff Rates in Adults With Cancer

SMUCLA implements high-touch wipe down intervention to address the need for environmental disinfection of cancer patient care areas.


By Erin K. McCreary, PharmD, BCPS BCIDP*

Latest:

Are Two Antibiotics Better Than One?

A commentary on β-lactam combination therapy for methicillin-resistant Staphylococcus aureus bacteremia.


Patrick Ayscue, DVM

Latest:

The Ripple Effect of Climate Change on Epidemic Risk

While rising temperatures and sea levels are often considered, changing climate patterns can have vast implications for epidemic risk as well.


KATY CAPERS, MA

Latest:

Five Ways ID Clinicians Can Take On Antibiotic Resistance: Highlights From the CDC's Latest Report

A death from an antibiotic-resistant infection occurs about every 15 minutes in the United States. The CDC’s 2019 threat report dives into national infection estimates and actions we can take to combat this threat.


PAUL LEONE, MD

Latest:

A Case of Disseminated Nocardia farcinica Presenting as Fever of Unknown Origin in a Transplant Patient

Outcomes in disseminated nocardiosis are variable and depend on patient factors.



Hilary C. Kelly, MPH

Latest:

Four Fungal Horsemen: Emerging Trends in Fungal Disease Epidemiology

New public health perspectives on aspergillosis, sporotrichosis, histoplasmosis, and coccidioidomycosis.


LOUISE DE SOUZA, PHARMD

Latest:

Long-Acting Anti-MRSA Agents: One Dose to Cure?

A review of the current literature and future directions.


Brian Dunleavy

Latest:

New Technology Enables Differentiation of Bacterial and Viral Infections

It can help inform appropriate antibiotic prescribing, but likely would only form part of testing protocol, experts say.


Aniruddha (Anu) Hazra, MD

Latest:

Living and Aging With HIV: Recognition and Management of Common Prescribing Pitfalls

With advancements in antiretroviral therapy, people with HIV are now living longer and developing age-related chronic conditions.



Sarah E. Rowan, MD

Latest:

With the Opioid Epidemic, Communities See Dramatic Increases in Infectious Diseases

Rising incidence of viral and bacterial infections has accompanied the opioid crisis, but it also presents new opportunities for multidisciplinary treatment and preventive care.


Kristen Zeitler, BS, PharmD, BCPS

Latest:

Antibiotic Stewardship Programs in the Hospital Setting: Guidance from the Centers for Disease Control and Prevention

While antibiotics serve a meaningful purpose in treating infections, appropriate use of these agents is needed in order to minimize adverse events.


Lily Rotman, MD

Latest:

New and Pipeline Antiretroviral Agents for the Treatment of HIV-1 Infection

This article seeks to review newer ART agents, as well as those in later stages of drug development, for the treatment of HIV-1 infection.


Sarah Anwar

Latest:

Will Brazil's Next Epidemic Come from Another Mosquito-Borne Virus?

As researchers discover Chikungunya-carrying mosquitoes in Brazil, a new study analyzes the impact of the Zika virus on the area.


Michael P. Veve, PharmD, MPH

Latest:

Using IL-6 Inhibitors to Treat COVID-19

Use of an IL-6 inhibitor has the potential to prevent the cytokine storm caused by severe COVID-19 infection.


Laura Joszt

Latest:

Clinicians Only Using New Antibiotics in Quarter of CRE Infection Cases, New Study Finds

As a growing number of infections become resistant to antibiotic medications, it is becoming crucially important that providers not only practice antibiotic stewardship but also use effective antibiotics when they are needed.


Karlyn D. Beer, PhD, MS

Latest:

Four Fungal Horsemen: Emerging Trends in Fungal Disease Epidemiology

New public health perspectives on aspergillosis, sporotrichosis, histoplasmosis, and coccidioidomycosis.


JASON KINDRACHUK, PHD

Latest:

What the 2018 DRC Ebola Epidemic Taught Us About Outbreak Response and Experimental Countermeasures

How has treating infections changed with the availability of experimental vaccines and therapeutics, and how can we apply this to COVID-19 today?



WILLIAM C. PACE, MD

Latest:

A Peculiar Finding in an Unfamiliar Patient

A rare metallo-ß-lactamase makes its way into the United States via an 84-year-old patient.


KALIN M. CLIFFORD, PHARMD, BCPS, BCGP

Latest:

Successful Stewardship Strategies in Long-Term Care Facilities

One successful model takes an engineering approach to patient safety outcomes focusing on work system improvements.


M. May Zhang

Latest:

ART Adherence in Transgender and Gender Nonconforming People

A recent study published in Transgender Health analyzed transgender and gender-nonconforming ART adherence based on the US Trans Survey, the largest survey of TGNC people in the United States.


Marilyn Bulloch, PharmD, BCPS

Latest:

Fighting Flu: Managing and Preventing Influenza with Antivirals

Taking into account the severity of this flu season, it is important that health care providers understand and choose the best treatment option for each patient.

© 2024 MJH Life Sciences

All rights reserved.